Under the theme “In pursuit of a life for every patient”, QIAGEN will host the Global Solid Tumor Summit to address the current challenges in cancer treatment and diagnostics. The global burden of cancer remains significant. Cancers account for nearly 10 million annual deaths worldwide, making cancer the second leading cause of death worldwide. Solid tumors make up more than 90% of those cancers.
The Global Solid Tumor Summit, to be held on April 25 and 26 as a hybrid event, will focus on the importance of integrating biomarker testing into cancer care, with the aim of improving patient outcomes.
The Global Solid Tumor Summit aims to unite researchers, oncologists, data specialists, and cancer survivors to address these challenges and raise awareness on the important relevance of biomarker testing both in research and in clinical practice.
The event will feature presentations by renowned experts, including Professor Umberto Malapelle, Department of Public Health, University Federico II of Naples, Italy.
